Paraneoplastic syndromes denote rare but notable phenomena caused by the tumour mediated release of bioactive substances. Peptide and non-peptide hormone causes are explored with a particular focus on pathogenesis, symptoms, diagnosis and treatment. Early detection and management of paraneoplastic syndromes can improve morbidly and mortality; definitive treatment remains effective surgical or anti-tumour therapies. Pituitary autoimmunity may provide a novel presentation of paraneoplastic syndromes for which further research is warranted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.beem.2022.101621 | DOI Listing |
Publication Analysis
Top Keywords
paraneoplastic syndromes
12
endocrine abnormality
4
paraneoplastic
4
abnormality paraneoplastic
4
paraneoplastic syndrome
4
syndrome paraneoplastic
4
syndromes denote
4
denote rare
4
rare notable
4
notable phenomena
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!